tradingkey.logo

Sight Sciences Inc

SGHT
5.820USD
+0.820+16.40%
Cierre 11/07, 16:00ETCotizaciones retrasadas 15 min
305.40MCap. mercado
PérdidaP/E TTM

Sight Sciences Inc

5.820
+0.820+16.40%

Más Datos de Sight Sciences Inc Compañía

Sight Sciences, Inc. is an eyecare technology company. The Company is focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. The Company operates through two segments: Surgical Glaucoma and Dry Eye. The product portfolio for the Surgical Glaucoma segment features the OMNI Surgical System, which is an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma and the SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. The product portfolio for the Dry Eye segment consists of the TearCare System (TearCare) for ophthalmologists and optometrists. TearCare is a wearable eyelid technology that delivers targeted and adjustable heat to the meibomian glands of the eyelids in adult patients with evaporative dry eye disease due to meibomian gland disfunction.

Información de Sight Sciences Inc

Símbolo de cotizaciónSGHT
Nombre de la empresaSight Sciences Inc
Fecha de salida a bolsaJul 15, 2021
Director ejecutivoMr. Paul Badawi
Número de empleados216
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 15
Dirección4040 Campbell Ave,
CiudadMENLO PARK
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal94025
Teléfono14158890550
Sitio Webhttps://www.sightsciences.com/
Símbolo de cotizaciónSGHT
Fecha de salida a bolsaJul 15, 2021
Director ejecutivoMr. Paul Badawi

Ejecutivos de Sight Sciences Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Badawi
Mr. Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
5.25M
-0.46%
Mr. Staffan Encrantz
Mr. Staffan Encrantz
Independent Chairman of the Board
Independent Chairman of the Board
1.99M
+9.78%
Dr. David Badawi, M.D.
Dr. David Badawi, M.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
1.67M
-0.36%
Mr. Gerhard F. (Gary) Burbach
Mr. Gerhard F. (Gary) Burbach
Independent Director
Independent Director
94.77K
+373.83%
Mr. Donald J. Zurbay, CPA
Mr. Donald J. Zurbay, CPA
Independent Director
Independent Director
75.35K
+69.71%
Ms. Alison Bauerlein
Ms. Alison Bauerlein
Chief Operating Officer, Principal Operating Officer
Chief Operating Officer, Principal Operating Officer
60.35K
-24.84%
Ms. Catherine Mazzacco
Ms. Catherine Mazzacco
Independent Director
Independent Director
30.95K
-54.78%
Mr. Jeremy Bragg Hayden, J.D.
Mr. Jeremy Bragg Hayden, J.D.
Chief Legal Officer
Chief Legal Officer
24.08K
-28.78%
Mr. Brenton Taylor
Mr. Brenton Taylor
Executive Vice President - Operations
Executive Vice President - Operations
--
--
Dr. Tamara R. Fountain, M.D.
Dr. Tamara R. Fountain, M.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Paul Badawi
Mr. Paul Badawi
President, Chief Executive Officer, Co-Founder, Director
President, Chief Executive Officer, Co-Founder, Director
5.25M
-0.46%
Mr. Staffan Encrantz
Mr. Staffan Encrantz
Independent Chairman of the Board
Independent Chairman of the Board
1.99M
+9.78%
Dr. David Badawi, M.D.
Dr. David Badawi, M.D.
Co-Founder, Chief Technology Officer, Director
Co-Founder, Chief Technology Officer, Director
1.67M
-0.36%
Mr. Gerhard F. (Gary) Burbach
Mr. Gerhard F. (Gary) Burbach
Independent Director
Independent Director
94.77K
+373.83%
Mr. Donald J. Zurbay, CPA
Mr. Donald J. Zurbay, CPA
Independent Director
Independent Director
75.35K
+69.71%
Ms. Alison Bauerlein
Ms. Alison Bauerlein
Chief Operating Officer, Principal Operating Officer
Chief Operating Officer, Principal Operating Officer
60.35K
-24.84%

Desglose de ingresos

Sin datos
Sin datos
Por negocio
Por región
Sin datos

Estadísticas de accionistas

Actualizado: mar., 19 de ago
Actualizado: mar., 19 de ago
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Badawi (Paul)
10.02%
Allegro Investment, Inc.
9.71%
KCK, Ltd.
8.35%
Long Focus Capital Management LLC
6.02%
BlackRock Institutional Trust Company, N.A.
4.44%
Otro
61.45%
Accionistas
Accionistas
Proporción
Badawi (Paul)
10.02%
Allegro Investment, Inc.
9.71%
KCK, Ltd.
8.35%
Long Focus Capital Management LLC
6.02%
BlackRock Institutional Trust Company, N.A.
4.44%
Otro
61.45%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
22.99%
Individual Investor
20.78%
Hedge Fund
19.34%
Investment Advisor/Hedge Fund
7.42%
Research Firm
0.89%
Pension Fund
0.21%
Bank and Trust
0.09%
Insurance Company
0.03%
Venture Capital
0.03%
Otro
28.21%

Participación institucional

Actualizado: mié., 1 de oct
Actualizado: mié., 1 de oct
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q3
187
26.71M
51.00%
-10.18M
2025Q2
210
37.29M
72.11%
-12.31M
2025Q1
220
37.28M
72.25%
-12.21M
2024Q4
223
37.28M
73.67%
-9.99M
2024Q3
223
36.71M
73.32%
-14.98M
2024Q2
223
36.40M
73.23%
-17.15M
2024Q1
223
36.63M
74.26%
-15.04M
2023Q4
226
36.66M
74.98%
-10.49M
2023Q3
225
39.02M
80.44%
-12.17M
2023Q2
222
40.39M
83.26%
-10.75M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Badawi (Paul)
5.27M
10.13%
-23.64K
-0.45%
Jul 01, 2025
Allegro Investment, Inc.
5.09M
9.71%
+1.06M
+26.47%
Mar 12, 2025
KCK, Ltd.
4.37M
8.35%
--
--
Jun 30, 2025
Long Focus Capital Management LLC
3.15M
6.02%
+25.00K
+0.80%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.33M
4.44%
+211.36K
+9.99%
Jun 30, 2025
Encrantz (Staffan)
1.99M
3.81%
+177.51K
+9.78%
Jun 06, 2025
The Vanguard Group, Inc.
1.80M
3.45%
+106.97K
+6.30%
Jun 30, 2025
Badawi (David)
1.68M
3.22%
+34.32K
+2.09%
Jul 17, 2025
Americana Partners, LLC
863.92K
1.65%
+863.92K
--
Jun 30, 2025
B Group, Inc.
930.00K
1.78%
+96.40K
+11.56%
Jun 30, 2025
Ver más

ETFs relacionados

Actualizado: jue., 6 de nov
Actualizado: jue., 6 de nov
Nombre
Proporción
iShares Micro-Cap ETF
0.03%
iShares US Small-Cap Equity Factor ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Avantis US Equity ETF
0%
Schwab U.S. Broad Market ETF
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
Ver más
iShares Micro-Cap ETF
Proporción0.03%
iShares US Small-Cap Equity Factor ETF
Proporción0.01%
Avantis US Small Cap Equity ETF
Proporción0.01%
Proshares Ultra Russell 2000
Proporción0.01%
iShares Russell 2000 Growth ETF
Proporción0.01%
ProShares UltraPro Russell2000
Proporción0.01%
Avantis US Equity ETF
Proporción0%
Schwab U.S. Broad Market ETF
Proporción0%
iShares Russell 2000 ETF
Proporción0%
Global X Russell 2000 ETF
Proporción0%

Dividendos

Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos

División de acciones

Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
KeyAI